India’s drug regulator has approved the Russian-made Coronavirus vaccine Sputnik V to join hands with the country’s second wave.
Sputnik V is the third coronavirus virus vaccine to have received emergency use approval after Kovild, developed by Oxford-AstraZeneca and developed by Kovaxin of the Serum Institute of India and the Indian firm Bharat Biotech.
The decision was made by the Drugs Controller General of India after a subject expert committee of the Central Drugs Standard Control Organization. Various important areas including safety, immunogenicity, efficacy data from overseas clinical studies, indications, age group, dosage schedule were discussed. The Ministry of Health of India said in a statement on Tuesday, caution, storage, warning, special interest adverse effects, risk benefit assessment….
Sputnik V, which has been approved for use in 60 countries around the world, in India, the company Drs. Made by Reddy’s laboratories.
Dr. In September, the pharmaceutical firm partnered with the Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V and distribute the vaccine in India, according to a press release issued by Reddy’s laboratories.
“We are very pleased to receive the Emergency Use Authority for Sputnik V in India. With increasing cases in India, vaccination is the most effective tool in our fight against COVID-19. Dr. GV Prasad, co-chairman and managing director of Reddy’s Laboratories, said, “This will help us contribute to our nation’s effort to vaccinate a significant proportion of our population.”
Larger image: India reported Is 161,736 On Tuesday, new cases of coronovirus, after a record single-day slight decline for six consecutive days, according to CNN data from the Ministry of Health.
Country has entered the total Is 13,689,453 Cases, including 171,058 Deaths and Is 1,264,698 Active case.
Total of 108,533,085 Vaccine supplements have been administered and so far, to health and border workers and people 45 years and older.
Several states have announced strict restrictions to prevent the spread of coronovirus. On Monday, the northern state of Haryana announced a nocturnal curfew, which came into immediate effect from 9:00 am to 5:00 pm until further notice.
The Capital Region of Delhi, which reported 11,491 cases on Monday, is preparing for an increase in cases.
The state government has announced to build 14 private hospitals in the capital into “full COVID-19” hospitals and asked them not to accept patients other than those infected with coronovirus. Nineteen private hospitals have been directed to reserve at least 80% of their ICU beds for Kovid patients, while a further 82 private hospitals have been asked to reserve 60% of their ICU beds for coronovirus patients. , According to an order tweeted by Delhi minister Satyendra. Jain